eardngam, alternative dysmenorrhea treatments besides NSAIDs: a randomized clinical trial
- Conditions
- Primary dysmenorrhea in young adult femalesdysmenorrhea, young adult, mefenamic acid, herbal medicine, Thai Traditional Medicine, randomized controlled trial
- Registration Number
- TCTR20200608004
- Brief Summary
This study concludes that the effectiveness of Leardngam for menstrual pain alleviation was comparable to that of mefenamic acid. It caused less gastrointestinal distress than mefenamic acid and had no effect on the menstrual cycle. Women with primary dysmenorrhea may use it as an alternative or a supplement.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 240
[1]Dysmenorrhea (Numeric rating scale >3)
[2]frequency of dysmenorrhea >80% of cycle
[3]Regular menstruation
[4]No underlying illness
[5]No other gynecologic disorders
[6]No concurrent of drug; steroid, NSAIDs, anti-platelet, anti-hypertension, magnesium hydroxide, cyclosporin
[7]Normal level of laboratory chemistry values
[8] No history of drug/herb allery
[9] understanding thai language
[10] Normal mental status
[11] not pregnant status
Medical complication during the trial
Drug allery during the trial
Abnormal laboratory chemistry values
Abnormal finding in pelvis by u/s
pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method dysmenorrhea intensity at the end of each cycle for three consecutive cycles Numeric rating scale,adverse effect at the end of each cycle for three consecutive cycles questionnaire, Fibser scale
- Secondary Outcome Measures
Name Time Method Menstrual characteristic at the end of each cycle for three consecutive cycles Questionnaires, and Pictorial Blood Loss Assessment Chart (PBAC)